Akzo Nobel NV

Pharmaceuticals
Netherlands
2016 Revenue (US$ Millions)$14,990
Revenue Growth (%)-4.46%
Net Income (US$ Millions)$1,024
Earnings Per Share (US$)$4.07
EPS Growth Rate (%)-1.79%
Profit Margin6.83%
Total Equity (US$ Millions)$6,919
Return on Equity (%)14.96%
Long Term Debt (US$ Millions)$2,792
Debt To Equity Ratio (%)0.40%
Total Assets (US$ Millions)$17,101
Current Assets (US$ Millions)$6,184
Current Liabilities (US$ Millions)$4,448
Cost of Goods Sold (US$ Millions)$8,647
Inventory Turnover5.39